What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Pricing

Get a demo

Ditto Bio

Visibility13

Vibe80

Businesses/Biotechnology/Ditto Bio

AI Visibility & Sentiment

Ditto Bio

Ditto Bio is a Y Combinator-backed biotechnology startup that discovers new drugs for autoimmune diseases by harnessing parasite biology. Their AI platform identifies therapeutic proteins from viruses, ticks, and worms that have evolved to modulate the immune system over millions of years.

Active Monitoring

dittobio.com

Biotechnology YC25-26

AI Visibility Score

13/100

Invisible

Sentiment Score

80/100

Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Ditto Bio today.

Ditto Bio is currently a ghost in the AI biotech conversation, completely missing from high-intent searches by Big Pharma scouts despite a niche presence in specialized immunology research. While competitors like Exscientia and Recursion dominate the narrative for AI-driven drug discovery, Ditto Bio only surfaces during deep technical inquiries into parasite biology or direct brand vibe checks.

Working in your favor

Secured the #1 position in AI Overviews for specialized research queries regarding parasite proteins and autoimmune disease treatment.

Maintains a high average position (2.5) among Senior Immunology Researchers, suggesting strong technical relevance within a narrow scientific niche.

Successfully maintains brand control in direct queries, achieving #1 rankings across all platforms when users specifically ask 'What do you know about Ditto Bio?'

Gaps to close

Zero percent mention rate on ChatGPT, the most widely used AI platform for strategic research and industry analysis.

Complete absence from critical category queries like 'emerging biotech startups' and 'most trusted AI-powered drug discovery platforms.'

Total failure to reach the Big Pharma Strategic Scout persona, who is currently being steered toward competitors like Exscientia, Roche, and Recursion.

Opportunities

Bridge the gap between specialized research and category leadership by positioning 'nature mining' as a superior alternative to synthetic-focused AI drug discovery.

Aggressively target the 'AI-driven drug discovery for autoimmune' query space to disrupt the current dominance of generalist platforms like Insilico Medicine.

Leverage the 30% mention rate among Biotech VCs to build high-authority backlinks that can force inclusion into the knowledge graphs of ChatGPT and Claude.

Highest-Impact Actions

Execute a digital PR strategy focused on 'AI-driven nature mining' for drug discovery in high-authority industry journals.

With a 0% mention rate on ChatGPT, the brand needs fresh, authoritative third-party data sources to be indexed as a category player.

Develop and publish a comprehensive whitepaper on AI's role in discovering novel immunotherapies from biological sources.

The Big Pharma Scout persona has zero visibility of the brand; technical category-specific content is required to bridge this gap.

Optimize site architecture and metadata to specifically target high-volume 'AI drug discovery leader' queries.

Competitors like Exscientia and Insilico are capturing the lion's share of mentions for general category queries where Ditto Bio is currently non-existent.

Value Proposition

Leveraging millions of years of parasite evolution to discover novel immunomodulatory proteins that can treat autoimmune diseases where the immune system attacks the body.

Overview

Mission

To discover new drugs by harnessing parasite biology, mining nature's untapped source of immunomodulatory proteins to treat autoimmune diseases.

Products & Services

AI-powered drug discovery platformTherapeutic protein identification from parasitesAutoimmune disease drug candidatesImmunomodulatory protein researchParasite biology analysis

Current State

Visibility Landscape

A high-level view of how Ditto Bio performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

	ChatGPT	Claude	Gemini	AI Overviews
Reputation1q Brand recognition & direct queries	97	97	97	97
“What do you know about Ditto Bio? What do they do and what's their reputation?”	#1	#1	#1	#1
Core4q Product/service category queries	0	36	35	35
“who are the leaders in AI-driven drug discovery for autoimmune disorders right now?”	No	#4	#20	#25
“research on using parasite proteins to treat autoimmune disease, which companies are doing this?”	No	No	No	#1
“most trusted AI-powered drug discovery platforms in 2026”	No	No	No	No
“help me find biotech platforms using AI to discover novel immunomodulatory proteins”	—	No	#21	No
Growth Areas1q Adjacent, aspirational & visionary	0	0	0	0
“emerging biotech startups using AI to mine nature for new drugs, any specific ones to watch?”	No	No	No	No

“What do you know about Ditto Bio? What do they do and what's their reputation?”

“who are the leaders in AI-driven drug discovery for autoimmune disorders right now?”

#20

#25

“research on using parasite proteins to treat autoimmune disease, which companies are doing this?”

“most trusted AI-powered drug discovery platforms in 2026”

“help me find biotech platforms using AI to discover novel immunomodulatory proteins”

—

#21

“emerging biotech startups using AI to mine nature for new drugs, any specific ones to watch?”

Competitive Landscape

Exscientia

21 mentions

Recursion Pharmaceuticals

18 mentions

Insilico Medicine

14 mentions

Atomwise

12 mentions

Schrödinger

12 mentions

BenevolentAI

11 mentions

AlphaFold

11 mentions

Roche

10 mentions

Generate Biomedicines

9 mentions

Bristol Myers Squibb

9 mentions

Ditto Bio

6 mentions

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Ditto Bio's AI visibility.

Key Findings

Strength

Secured the #1 position in AI Overviews for specialized research queries regarding parasite proteins and autoimmune disease treatment.

Strength

Maintains a high average position (2.5) among Senior Immunology Researchers, suggesting strong technical relevance within a narrow scientific niche.

Strength

Successfully maintains brand control in direct queries, achieving #1 rankings across all platforms when users specifically ask 'What do you know about Ditto Bio?'

Recommended Actions

Execute a digital PR strategy focused on 'AI-driven nature mining' for drug discovery in high-authority industry journals.

With a 0% mention rate on ChatGPT, the brand needs fresh, authoritative third-party data sources to be indexed as a category player.

Develop and publish a comprehensive whitepaper on AI's role in discovering novel immunotherapies from biological sources.

The Big Pharma Scout persona has zero visibility of the brand; technical category-specific content is required to bridge this gap.

Optimize site architecture and metadata to specifically target high-volume 'AI drug discovery leader' queries.

Competitors like Exscientia and Insilico are capturing the lion's share of mentions for general category queries where Ditto Bio is currently non-existent.

Content Engineering

Content Ideas

Content designed to help AI agents learn about your category and recommend your brand.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Drug Discovery Innovation & AI Strategy(2 queries)

“who are the leaders in AI-driven drug discovery for autoimmune disorders right now?”

1/4 platforms mentioned

Core

ChatGPT

1.Exscientia

2.Insitro

3.Recursion Pharmaceuticals

4.Atomwise

5.Cyclica

+17 more

Claude

1.DeepMind

2.Alphabet

3.AlphaFold

4.Exscientia

5.Recursion Pharmaceuticals

+9 more

Gemini

1.Exscientia

2.Sanofi

3.BenevolentAI

4.Benevolent Platform

5.Eli Lilly

+18 more

AI Overviews

1.DeepCure

2.DC-15442

3.Genesis Therapeutics

4.GEMS

5.Gilead Sciences

25.Ditto Biosciences

+21 more

“help me find biotech platforms using AI to discover novel immunomodulatory proteins”

0/3 platforms mentioned

Core

The Big Pharma Strategic Scout · Head of External Innovation / Business Development

Claude

1.Exscientia

2.Generate

3.Absci

4.Generate Biomedicines

5.Recursion Pharmaceuticals

+6 more

Gemini

1.AlphaFold

2.EvolutionaryScale

3.Profluent

4.LabGenius

5.Peptilogics

+10 more

AI Overviews

1.BioMap

2.xTrimo

3.Generate Biomedicines

4.Novartis

5.Amgen

+16 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

11 Innovative Companies Using AI for Drug Discovery - Cure.

wewillcure.com

Ditto Bio

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Content Ideas

Sample Conversations

Citations

Brand Voice & Style

Investors

Engineer content that makes AI agents recommend you

Explore Biotechnology

Start gettingrecommended by AI.

Frequently asked questions

Ditto Bio

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Content Ideas

Sample Conversations

Citations

Brand Voice & Style

Investors

Engineer content that makes AI agents recommend you

Explore Biotechnology

Start gettingrecommended by AI.

Frequently asked questions

Start getting
recommended by AI.

Start getting
recommended by AI.